In conclusion, ARRB2 activates β-catenin in CML and bcCML and plays a crucial role in regulating self-renewal and differentiation in leukemic cancer stem cell populations promoting initiation and progression of the disease. This evidence concerns the gene ARRB2 and chronic myelogenous leukemia, BCR-ABL1 positive.